Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial

Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Advances and Contributions

(2014) D. M. Nathan et al.   DIABETES

Mineralocorticoid Receptor Blockade Reduced Oxidative Stress in Renal Transplant Recipients: A Double-Blind, Randomized Pilot Study

(2013) Marcos Ojeda-Cervantes et al.   AMERICAN JOURNAL OF NEPHROLOGY

Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: An emerging paradigm in diabetic nephropathy

(2013) Thomas A. Mavrakanas et al.   European Journal of Internal Medicine

Eplerenone-Mediated Aldosterone Blockade Prevents Renal Fibrosis by Reducing Renal Inflammation, Interstitial Cell Proliferation and Oxidative Stress

(2013) Hui Chen et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Long-term effects of addition of mineralocorticoid receptor antagonist to angiotensin II receptor blocker in patients with diabetic nephropathy: a randomized clinical trial

(2013) A. Esteghamati et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

GFR Estimation Using Standardized Serum Cystatin C in Japan

(2012) Masaru Horio et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Renoprotective effects of mineralocorticoid receptor blockers in patients with proteinuric kidney diseases

(2012) E. Morales et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009)

(2012) Shigeru Nakai et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Urinary Neutrophil Gelatinase-Associated Lipocalin Levels in Comparison with Glomerular Filtration Rate for Evaluation of Renal Function in Patients with Diabetic Chronic Kidney Disease

(2012) Kwang-Sook Woo et al.   Diabetes & Metabolism Journal

Relationship Between Urinary Angiotensinogen and Salt Sensitivity of Blood Pressure in Patients With IgA Nephropathy

(2011) Yoshio Konishi et al.   HYPERTENSION

Revised Equations for Estimated GFR From Serum Creatinine in Japan

(2009) Seiichi Matsuo et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Mineralocorticoid Receptor Blockade Enhances the Antiproteinuric Effect of an Angiotensin II Blocker through Inhibiting Podocyte Injury in Type 2 Diabetic Rats

(2009) A. Nishiyama et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

(2009) U. F. Mehdi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review

(2008) Andrew S. Bomback et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?

(2008) R. Bilous   DIABETIC MEDICINE

Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of an Aldosterone Blocker, Spironolactone, to Combination Treatment with an Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker

(2008) Yoshiyuki FURUMATSU et al.   HYPERTENSION RESEARCH

Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes: A Post-Hoc Analysis of the Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study

(2008) Hirofumi Makino et al.   HYPERTENSION RESEARCH

Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

(2008) Shigeru Shibata et al.   NATURE MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE